Genetic determinants of bovine leukemia virus pathogenesis

AIDS Research and Human Retroviruses

Volumn 16, Issue 16, 2000, Pages 1787-1795

  Willems, L ^a   Burny, A ^a   Collete, D ^a   Dangoisse, O ^a   Dequiedt, F ^a   Gatot, J S ^a   Kerkhofs, P ^b   Lefebvre, L ^a   Merezak, C ^a   Peremans, T ^a   Portetelle, D ^a   Twizere, J C ^a   Kettmann, R ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CATTLE; HEMATOPOIETIC SYSTEM; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETROVIRUS; SHEEP; VIRUS INFECTIVITY; VIRUS REPLICATION;

ANIMALS; CATTLE; CATTLE DISEASES; ENZOOTIC BOVINE LEUKOSIS; LEUKEMIA VIRUS, BOVINE; SHEEP; SHEEP DISEASES;

EID: 0034331096     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050193326     Document Type: Article

References (68)

1. Bovine leukemia virus involvement in enzootic bovine leukosis
2. Bovine lymphosarcoma
3. Bovine leukaemia: Facts and hypotheses derived from the study of an infectious cancer
4. Bovine leukemia virus
5. Pathobiology of bovine leukemia virus
6. T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine
7. Detrimental effect of bovine leukemia virus (BLV) on the immunological state of cattle
8. Food animal and poultry retroviruses and human health
9. Natural transmission of bovine leukemia virus in dairy and beef cattle
10. Economics of bovine leukemia virus infection
11. Bovine leukemia virus as a model for human T-cell leukemia virus
12. Bovine leukemia virus genes in the DNA of leukemic cattle
13. Bovine leukemia Virus: An exogenous RNA oncogenic virus
14. Biochemical studies on enzootic and sporadic types of bovine leucosis
15. Induction of lymphoid tumors in sheep with cell-free preparations of bovine leukemia virus
16. Pathology of lymphosarcoma in sheep induced with bovine leukemia virus
17. Induction of lymphosarcoma in sheep by bovine leukemia virus
18. Experimental crosstransmissions of bovine leukemia virus (BLV) between several animal species
19. Goat lymphosarcoma from bovine leukemia virus
20. Induction of immune deficiency syndrome in rabbits by bovine leukaemia virus
21. The BLV-induced leukemia-lymphosarcoma complex in sheep
22. Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction
23. Induction of leukemia in chicken by bovine leukemia virus due to insertional mutagenesis
24. Suppression of immunological responses in rabbits experimentally infected with bovine leukemia virus
25. Engraftment of bovine leukemia virus infected lymphocytes into SCID mice
26. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex
27. In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures
28. Construction of a recombinant bovine leukemia virus vector for analysis of virus infectivity
29. Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus
30. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus
31. The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts
32. The prevalence of proviral bovine, leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection
33. Stabilization of the p53 gene product in two bovine leukemia virus infected cell lines
34. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep
35. Wild type p53 reduces the size of tumors caused by bovine leukemia virus-infected cells
36. Predominant p53 mutations in enzootic bovine leukemic cell lines
37. p53 mutation as a potential cellular factor for tumor development in enzootic bovine leukosis
38. Point mutation of p53 tumor suppressor gene in bovine leukemia virus-induced lymphosarcoma
39. Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma
40. Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis
41. Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B cell apoptosis
42. Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep
43. Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes
44. Increased ratio of bcl-2/bax expression is associated with bovine leukemia virus-induced leukemogenesis in cattle
45. Replication of bovine leukemia virus in monolayer cell cultures
46. In vivo transfection of bovine leukemia provirus into sheep
47. In vivo infection of sheep by bovine leukemia virus mutants
48. Even transcriptionally competent proviruses are silent in bovine leukemia virus induced tumor cells
49. Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development
50. In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene
51. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein
52. Pathogenicity of molecularly cloned bovine leukemia virus
53. The major homology region of bovine leukaemia virus p24gag is required for viral infectivity in vivo
54. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads
55. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames
56. Protective effects of a live attenuated bovine leukaemia virus vaccine with deletion in the R3 and G4 genes
57. Long-term protection against bovine leukaemia virus replication in cattle and sheep
58. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells
59. Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins
60. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo
61. Bovine leukemia virus transcription is controlled by a virus-encoded transacting factor and by cis-acting response elements
62. The bovine leukemia virus p34 is a transactivator protein
63. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation
64. Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential
65. Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation
66. Discordance between bovine leukemia virus Tax immobilization in vitro and oncogenicity in vivo